glp-1 receptor agonists and cardiovascular outcome trials an update Efficacy of GLP‐1 in patients with obesity heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled - Talavera - 2025 Summary of cardiovascular outcome trials
Description
No funding was received for this research
Gallstones Gallstones(cholelithiasis) are caused by changes in bile composition and biliary motility
Market Segment This study forecasts revenue at global, regional, and country levels from 2022 to 2032
doi: 10.1007/s00125-015-3727-0
[Published correction appears in Lancet
